Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.
2.

Emerging Tools for Stroke Prevention in Atrial Fibrillation.

Voukalis C, Lip GY, Shantsila E.

EBioMedicine. 2016 Jan 15;4:26-39. doi: 10.1016/j.ebiom.2016.01.017. eCollection 2016 Feb. Review.

3.

The AIMS65 Score Is a Useful Predictor of Mortality in Patients with Nonvariceal Upper Gastrointestinal Bleeding: Urgent Endoscopy in Patients with High AIMS65 Scores.

Park SW, Song YW, Tak DH, Ahn BM, Kang SH, Moon HS, Sung JK, Jeong HY.

Clin Endosc. 2015 Nov;48(6):522-7. doi: 10.5946/ce.2015.48.6.522. Epub 2015 Nov 30.

4.

Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.

De Sensi F, De Potter T, Cresti A, Severi S, Breithardt G.

Cardiovasc Diagn Ther. 2015 Oct;5(5):364-73. doi: 10.3978/j.issn.2223-3652.2015.06.03. Review.

5.

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.

Noseworthy PA, Yao X, Deshmukh AJ, Van Houten H, Sangaralingham LR, Siontis KC, Piccini JP Sr, Asirvatham SJ, Friedman PA, Packer DL, Gersh BJ, Shah ND.

J Am Heart Assoc. 2015 Nov 5;4(11). pii: e002597. doi: 10.1161/JAHA.115.002597.

6.

Renal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs re-expressed 4 variable modification of diet in renal disease.

Abumuaileq RR, Abu-Assi E, López-López A, Raposeiras-Roubin S, Rodríguez-Mañero M, Martínez-Sande L, García-Seara FJ, Fernandez-López XA, González-Juanatey JR.

World J Cardiol. 2015 Oct 26;7(10):685-94. doi: 10.4330/wjc.v7.i10.685.

7.

Net Clinical Benefits of Guidelines and Decision Tool Recommendations for Oral Anticoagulant Use among Patients with Atrial Fibrillation.

Shewale AR, Johnson JT, Li C, Nelsen D, Martin BC.

J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2845-53. doi: 10.1016/j.jstrokecerebrovasdis.2015.08.019. Epub 2015 Oct 21.

PMID:
26482369
8.

Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study.

Wu C, McMurtry MS, Sandhu RK, Youngson E, Ezekowitz JA, Kaul P, McAlister FA.

PLoS One. 2015 Oct 14;10(10):e0140607. doi: 10.1371/journal.pone.0140607. eCollection 2015.

9.

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.

O'Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, Pencina MJ, Piccini JP, Peterson ED.

Eur Heart J. 2015 Dec 7;36(46):3258-64. doi: 10.1093/eurheartj/ehv476. Epub 2015 Sep 29.

10.

Assessing the risk of recurrent venous thromboembolism--a practical approach.

Fahrni J, Husmann M, Gretener SB, Keo HH.

Vasc Health Risk Manag. 2015 Aug 17;11:451-9. doi: 10.2147/VHRM.S83718. eCollection 2015. Review.

11.

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.

Ye S, Cheng B, Lip GY, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Qian M, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S; WARCEF Investigators.

Am J Cardiol. 2015 Sep 15;116(6):904-12. doi: 10.1016/j.amjcard.2015.06.016. Epub 2015 Jun 24.

PMID:
26189039
12.

Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality.

Park YK, Lee MJ, Kim JH, Kim SJ, Kim JS, Lee SY, Bang OY.

J Stroke. 2015 May;17(2):192-8. doi: 10.5853/jos.2015.17.2.192. Epub 2015 May 29.

13.

Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack.

Patel PA, Zhao X, Fonarow GC, Lytle BL, Smith EE, Xian Y, Bhatt DL, Peterson ED, Schwamm LH, Hernandez AF.

Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):383-92. doi: 10.1161/CIRCOUTCOMES.114.000907. Epub 2015 Jun 9.

PMID:
26058721
14.

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.

Kooiman J, van Hagen N, Iglesias Del Sol A, Planken EV, Lip GY, van der Meer FJ, Cannegieter SC, Klok FA, Huisman MV.

PLoS One. 2015 Apr 23;10(4):e0122520. doi: 10.1371/journal.pone.0122520. eCollection 2015.

15.

Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.

Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):619-27. doi: 10.1002/pds.3769. Epub 2015 Apr 8.

16.

Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation.

Barnes GD, Kanthi Y, Froehlich JB.

Vasc Med. 2015 Apr;20(2):143-52. doi: 10.1177/1358863X14566429. Review.

17.

Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.

Chamberlain AM, Gersh BJ, Mills RM, Klaskala W, Alonso A, Weston SA, Roger VL.

Am J Cardiol. 2015 Apr 15;115(8):1042-8. doi: 10.1016/j.amjcard.2015.01.534. Epub 2015 Jan 31.

18.
19.

Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation.

Sen S, Dahlberg KW.

Am J Med Sci. 2014 Dec;348(6):513-21. doi: 10.1097/MAJ.0000000000000349. Review.

20.

Stroke and bleeding risk in atrial fibrillation.

Senoo K, Lane D, Lip GY.

Korean Circ J. 2014 Sep;44(5):281-90. doi: 10.4070/kcj.2014.44.5.281. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk